In vivo proton magnetic resonance spectroscopy in patients with mood disorders: A technically oriented review
Proton MR spectroscopy (1HMRS) has been extensively used among mood disorders patients. A review of the published literature in 1HMRS studies of mood disorders was carried out for the period 1991 to July 2006. Of 71 1HMRS studies, 77.5% were done at 1.5T and 66.2% used single voxel sequences (SVS),...
Gespeichert in:
Veröffentlicht in: | Journal of magnetic resonance imaging 2007-12, Vol.26 (6), p.1378-1389 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1389 |
---|---|
container_issue | 6 |
container_start_page | 1378 |
container_title | Journal of magnetic resonance imaging |
container_volume | 26 |
creator | Capizzano, Aristides A. Jorge, Ricardo E. Acion, Laura C. Robinson, Robert G. |
description | Proton MR spectroscopy (1HMRS) has been extensively used among mood disorders patients. A review of the published literature in 1HMRS studies of mood disorders was carried out for the period 1991 to July 2006. Of 71 1HMRS studies, 77.5% were done at 1.5T and 66.2% used single voxel sequences (SVS), implying limitations of spectral resolution and anatomic coverage, respectively. In all, 47.9% of studies relied on creatine (Cr) as internal signal standard, although Cr changes were reported in major depression (MD). Most reported metabolic alterations related to mood state affected the left frontal lobe. Depressed adult and pediatric MD patients had reduced glutamate (Glu) in frontal lobe regions, which reversed with successful treatment. A consistent reduction of N‐acetyl‐aspartate (NAA) was reported in the hippocampal formation among bipolar disorder (BD) patients, along with an increment in frontal Glu. The differences in results of 1HMRS studies in mood disorders reflect heterogeneity of technical factors and subject selection. Future studies should benefit from higher spectral resolution and more extensive anatomic coverage as well as standardized data‐processing protocols and subject selection criteria. J. Magn. Reson. Imaging 2007. © 2007 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/jmri.21144 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69045708</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69045708</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4014-46df1030215a27bd9a5b9cda58af2e27a50c26257ae1358cf2f6f00520c60f5c3</originalsourceid><addsrcrecordid>eNp9kMFO3DAURS1UBJSy4QOQV10ghT47cZywQ6MynRaoVFGxtDzOSzEkdmp7Zpi_b4aZll1X7y3OPdK9hJwyuGAA_NNTH-wFZ6wo9sgRE5xnXFTlu_EHkWesAnlI3sf4BAB1XYgDcshkXVZVJY5IP3N0aZeeDsEn72ivfzlM1tCA0TvtDNI4oEnBR-OHNbWODjpZdCnSlU2PtPe-oY2NPjQY4iW9ognNo7NGd92a-rBBsRl1S4urD2S_1V3Ek909Jj-vP99PvmQ336ezydVNZgpgRVaUTcsgB86E5nLe1FrMa9NoUemWI5dagOElF1Ijy0VlWt6WLYDgYEpohcmPycetd2z1e4Exqd5Gg12nHfpFVGUNhZBQjeD5FjRjwRiwVUOwvQ5rxUBtxlWbcdXruCN8trMu5j02b-huzRFgW2BlO1z_R6W-3v6Y_ZVm24yNCV_-ZXR4VqXMpVAPd1M14d_ui2ktlcz_AJlGlYc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69045708</pqid></control><display><type>article</type><title>In vivo proton magnetic resonance spectroscopy in patients with mood disorders: A technically oriented review</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Capizzano, Aristides A. ; Jorge, Ricardo E. ; Acion, Laura C. ; Robinson, Robert G.</creator><creatorcontrib>Capizzano, Aristides A. ; Jorge, Ricardo E. ; Acion, Laura C. ; Robinson, Robert G.</creatorcontrib><description>Proton MR spectroscopy (1HMRS) has been extensively used among mood disorders patients. A review of the published literature in 1HMRS studies of mood disorders was carried out for the period 1991 to July 2006. Of 71 1HMRS studies, 77.5% were done at 1.5T and 66.2% used single voxel sequences (SVS), implying limitations of spectral resolution and anatomic coverage, respectively. In all, 47.9% of studies relied on creatine (Cr) as internal signal standard, although Cr changes were reported in major depression (MD). Most reported metabolic alterations related to mood state affected the left frontal lobe. Depressed adult and pediatric MD patients had reduced glutamate (Glu) in frontal lobe regions, which reversed with successful treatment. A consistent reduction of N‐acetyl‐aspartate (NAA) was reported in the hippocampal formation among bipolar disorder (BD) patients, along with an increment in frontal Glu. The differences in results of 1HMRS studies in mood disorders reflect heterogeneity of technical factors and subject selection. Future studies should benefit from higher spectral resolution and more extensive anatomic coverage as well as standardized data‐processing protocols and subject selection criteria. J. Magn. Reson. Imaging 2007. © 2007 Wiley‐Liss, Inc.</description><identifier>ISSN: 1053-1807</identifier><identifier>EISSN: 1522-2586</identifier><identifier>DOI: 10.1002/jmri.21144</identifier><identifier>PMID: 17968885</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Aspartic Acid - analogs & derivatives ; Aspartic Acid - metabolism ; bipolar ; Brain Chemistry - physiology ; Creatine - metabolism ; depression ; Frontal Lobe - chemistry ; Frontal Lobe - metabolism ; Glutamates - metabolism ; Hippocampus - chemistry ; Hippocampus - metabolism ; Humans ; Image Processing, Computer-Assisted ; magnetic resonance spectroscopy ; Magnetic Resonance Spectroscopy - methods ; mood ; Mood Disorders - metabolism ; neurochemistry ; Protons</subject><ispartof>Journal of magnetic resonance imaging, 2007-12, Vol.26 (6), p.1378-1389</ispartof><rights>Copyright © 2007 Wiley‐Liss, Inc.</rights><rights>(c) 2007 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4014-46df1030215a27bd9a5b9cda58af2e27a50c26257ae1358cf2f6f00520c60f5c3</citedby><cites>FETCH-LOGICAL-c4014-46df1030215a27bd9a5b9cda58af2e27a50c26257ae1358cf2f6f00520c60f5c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjmri.21144$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjmri.21144$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17968885$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Capizzano, Aristides A.</creatorcontrib><creatorcontrib>Jorge, Ricardo E.</creatorcontrib><creatorcontrib>Acion, Laura C.</creatorcontrib><creatorcontrib>Robinson, Robert G.</creatorcontrib><title>In vivo proton magnetic resonance spectroscopy in patients with mood disorders: A technically oriented review</title><title>Journal of magnetic resonance imaging</title><addtitle>J. Magn. Reson. Imaging</addtitle><description>Proton MR spectroscopy (1HMRS) has been extensively used among mood disorders patients. A review of the published literature in 1HMRS studies of mood disorders was carried out for the period 1991 to July 2006. Of 71 1HMRS studies, 77.5% were done at 1.5T and 66.2% used single voxel sequences (SVS), implying limitations of spectral resolution and anatomic coverage, respectively. In all, 47.9% of studies relied on creatine (Cr) as internal signal standard, although Cr changes were reported in major depression (MD). Most reported metabolic alterations related to mood state affected the left frontal lobe. Depressed adult and pediatric MD patients had reduced glutamate (Glu) in frontal lobe regions, which reversed with successful treatment. A consistent reduction of N‐acetyl‐aspartate (NAA) was reported in the hippocampal formation among bipolar disorder (BD) patients, along with an increment in frontal Glu. The differences in results of 1HMRS studies in mood disorders reflect heterogeneity of technical factors and subject selection. Future studies should benefit from higher spectral resolution and more extensive anatomic coverage as well as standardized data‐processing protocols and subject selection criteria. J. Magn. Reson. Imaging 2007. © 2007 Wiley‐Liss, Inc.</description><subject>Aspartic Acid - analogs & derivatives</subject><subject>Aspartic Acid - metabolism</subject><subject>bipolar</subject><subject>Brain Chemistry - physiology</subject><subject>Creatine - metabolism</subject><subject>depression</subject><subject>Frontal Lobe - chemistry</subject><subject>Frontal Lobe - metabolism</subject><subject>Glutamates - metabolism</subject><subject>Hippocampus - chemistry</subject><subject>Hippocampus - metabolism</subject><subject>Humans</subject><subject>Image Processing, Computer-Assisted</subject><subject>magnetic resonance spectroscopy</subject><subject>Magnetic Resonance Spectroscopy - methods</subject><subject>mood</subject><subject>Mood Disorders - metabolism</subject><subject>neurochemistry</subject><subject>Protons</subject><issn>1053-1807</issn><issn>1522-2586</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFO3DAURS1UBJSy4QOQV10ghT47cZywQ6MynRaoVFGxtDzOSzEkdmp7Zpi_b4aZll1X7y3OPdK9hJwyuGAA_NNTH-wFZ6wo9sgRE5xnXFTlu_EHkWesAnlI3sf4BAB1XYgDcshkXVZVJY5IP3N0aZeeDsEn72ivfzlM1tCA0TvtDNI4oEnBR-OHNbWODjpZdCnSlU2PtPe-oY2NPjQY4iW9ognNo7NGd92a-rBBsRl1S4urD2S_1V3Ek909Jj-vP99PvmQ336ezydVNZgpgRVaUTcsgB86E5nLe1FrMa9NoUemWI5dagOElF1Ijy0VlWt6WLYDgYEpohcmPycetd2z1e4Exqd5Gg12nHfpFVGUNhZBQjeD5FjRjwRiwVUOwvQ5rxUBtxlWbcdXruCN8trMu5j02b-huzRFgW2BlO1z_R6W-3v6Y_ZVm24yNCV_-ZXR4VqXMpVAPd1M14d_ui2ktlcz_AJlGlYc</recordid><startdate>200712</startdate><enddate>200712</enddate><creator>Capizzano, Aristides A.</creator><creator>Jorge, Ricardo E.</creator><creator>Acion, Laura C.</creator><creator>Robinson, Robert G.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200712</creationdate><title>In vivo proton magnetic resonance spectroscopy in patients with mood disorders: A technically oriented review</title><author>Capizzano, Aristides A. ; Jorge, Ricardo E. ; Acion, Laura C. ; Robinson, Robert G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4014-46df1030215a27bd9a5b9cda58af2e27a50c26257ae1358cf2f6f00520c60f5c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aspartic Acid - analogs & derivatives</topic><topic>Aspartic Acid - metabolism</topic><topic>bipolar</topic><topic>Brain Chemistry - physiology</topic><topic>Creatine - metabolism</topic><topic>depression</topic><topic>Frontal Lobe - chemistry</topic><topic>Frontal Lobe - metabolism</topic><topic>Glutamates - metabolism</topic><topic>Hippocampus - chemistry</topic><topic>Hippocampus - metabolism</topic><topic>Humans</topic><topic>Image Processing, Computer-Assisted</topic><topic>magnetic resonance spectroscopy</topic><topic>Magnetic Resonance Spectroscopy - methods</topic><topic>mood</topic><topic>Mood Disorders - metabolism</topic><topic>neurochemistry</topic><topic>Protons</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Capizzano, Aristides A.</creatorcontrib><creatorcontrib>Jorge, Ricardo E.</creatorcontrib><creatorcontrib>Acion, Laura C.</creatorcontrib><creatorcontrib>Robinson, Robert G.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of magnetic resonance imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Capizzano, Aristides A.</au><au>Jorge, Ricardo E.</au><au>Acion, Laura C.</au><au>Robinson, Robert G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vivo proton magnetic resonance spectroscopy in patients with mood disorders: A technically oriented review</atitle><jtitle>Journal of magnetic resonance imaging</jtitle><addtitle>J. Magn. Reson. Imaging</addtitle><date>2007-12</date><risdate>2007</risdate><volume>26</volume><issue>6</issue><spage>1378</spage><epage>1389</epage><pages>1378-1389</pages><issn>1053-1807</issn><eissn>1522-2586</eissn><abstract>Proton MR spectroscopy (1HMRS) has been extensively used among mood disorders patients. A review of the published literature in 1HMRS studies of mood disorders was carried out for the period 1991 to July 2006. Of 71 1HMRS studies, 77.5% were done at 1.5T and 66.2% used single voxel sequences (SVS), implying limitations of spectral resolution and anatomic coverage, respectively. In all, 47.9% of studies relied on creatine (Cr) as internal signal standard, although Cr changes were reported in major depression (MD). Most reported metabolic alterations related to mood state affected the left frontal lobe. Depressed adult and pediatric MD patients had reduced glutamate (Glu) in frontal lobe regions, which reversed with successful treatment. A consistent reduction of N‐acetyl‐aspartate (NAA) was reported in the hippocampal formation among bipolar disorder (BD) patients, along with an increment in frontal Glu. The differences in results of 1HMRS studies in mood disorders reflect heterogeneity of technical factors and subject selection. Future studies should benefit from higher spectral resolution and more extensive anatomic coverage as well as standardized data‐processing protocols and subject selection criteria. J. Magn. Reson. Imaging 2007. © 2007 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>17968885</pmid><doi>10.1002/jmri.21144</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1053-1807 |
ispartof | Journal of magnetic resonance imaging, 2007-12, Vol.26 (6), p.1378-1389 |
issn | 1053-1807 1522-2586 |
language | eng |
recordid | cdi_proquest_miscellaneous_69045708 |
source | Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Aspartic Acid - analogs & derivatives Aspartic Acid - metabolism bipolar Brain Chemistry - physiology Creatine - metabolism depression Frontal Lobe - chemistry Frontal Lobe - metabolism Glutamates - metabolism Hippocampus - chemistry Hippocampus - metabolism Humans Image Processing, Computer-Assisted magnetic resonance spectroscopy Magnetic Resonance Spectroscopy - methods mood Mood Disorders - metabolism neurochemistry Protons |
title | In vivo proton magnetic resonance spectroscopy in patients with mood disorders: A technically oriented review |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A20%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vivo%20proton%20magnetic%20resonance%20spectroscopy%20in%20patients%20with%20mood%20disorders:%20A%20technically%20oriented%20review&rft.jtitle=Journal%20of%20magnetic%20resonance%20imaging&rft.au=Capizzano,%20Aristides%20A.&rft.date=2007-12&rft.volume=26&rft.issue=6&rft.spage=1378&rft.epage=1389&rft.pages=1378-1389&rft.issn=1053-1807&rft.eissn=1522-2586&rft_id=info:doi/10.1002/jmri.21144&rft_dat=%3Cproquest_cross%3E69045708%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69045708&rft_id=info:pmid/17968885&rfr_iscdi=true |